Head of Business Development
Lausanne, Switzerland - October 3, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Varelas, a distributor for clinical applications in Greece. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Varelas’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.
Nikolaos Varelas, CEO of Varelas, said: ‘This new partnership helps us to deliver high-quality, state-of-the-art bioinformatics services in the clinical and research fields, along with our wide portfolio of pioneering and innovative library preparation kits, advanced automation solutions and ancillary equipment for NGS.’
Andreas Massouras, CEO and Founder of Saphetor SA, commented: ‘We are excited to count Varelas among our regional distributors for our bioinformatics tools, and we are prepared to work closely with their team to provide their clients with an integrated solution for diagnostics purposes.’
About Varelas SA
Varelas S.A. is a Greek customer-oriented dynamic Distributor of in Vitro Diagnostic and Life-sciences solutions in Greece and Cyprus. The company’s mission is to play a leading role in the continuous development of Health and Life-science research markets of its area, by identifying and answering successfully to the high level, multifaceted and ever evolving needs of today’s Health and Life-science research professionals in the most reliable, thorough and up-to-date way. The combination of Varelas ‘s high calibre personnel (75% are scientists and 60% of them hold post-graduate degrees), constantly evolving and well established processes and deep market knowledge, accumulated through the 42 years of its successful presence in the market, have been setting the basis of its characteristic role as a strong market driver towards introduction and implementation of innovative solutions, platforms and state-of-the-art technologies in the Greek and Cypriot markets.
About Saphetor SA
Saphetor SA, is a Swiss precision-medicine company dedicated to large-scale identification and interpretation of human genetic variants by leveraging proprietary algorithms and expert domain knowledge. Saphetor is the creator of VarSome, a suite of intuitive and data-driven bioinformatics solutions both for clinicians and researchers. VarSome.com search engine and professional community is freely accessible, featuring a widely-recognized community-driven knowledge base that enables flexible queries across more than 30 genetic and genomic data resources. VarSome Pro and VarSome Clinical are professional editions of VarSome with powerful functionality and further sophisticated data-mining and analysis tools. While VarSome Pro serves researchers, VarSome Clinical is a clinically-accredited platform allowing fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels, which helps clinicians reach faster and more accurate diagnoses and treatment decisions for genetic conditions.